| 004-41 |
Pro-SAAS (221-239) (Rat) |
AVDQDLGPEV PPENVLGAL |
1931.99 |
| 004-42 |
Pro-SAAS (221-240) (Rat) |
AVDQDLGPEV PPENVLGALL |
2045.08 |
| 004-43 |
Pro-SAAS (221-241) (Rat) |
AVDQDLGPEV PPENVLGALLR |
2201.18 |
| 004-55 |
Pro-SAAS (221-242) / PEN (Rat) |
AVDQDLGPEV PPENVLGALLRV |
2300.25 |
| 004-56 |
Pro-SAAS (245-260) / Big LEN (Rat) |
LENSSPQAPA RRLLPP |
1744.96 |
| 004-53 |
Pro-SAAS (245-260) / Big LEN (Human) |
LETPAPQVPA RRLLPP |
1755.09 |
| 004-59 |
Pro-SAAS (243-258) / Big LEN (Mouse) |
LENPSPQAPA RRLLPP |
1756.04 |
| 062-28 |
Prothyroliberin (25-50) (Rat) |
LPEAAQEEGA VTPDLPGLEN VQVRPE |
2757.4 |
| 062-27 |
Prothyroliberin (83-103) (Rat) |
EEEEKDIEAE ERGDLGEGGA W |
2347.02 |
| 062-23 |
Prothyroliberin (178-199) (Rat) |
FIDPELQRSW EEKEGEGVLM PE |
2617.25 |
| 053-13 |
Pancreastatin / Chromogranin A (280-314)-Amide (Rat) |
DDGQSESQAV NGKTGASEAV PSEGKGELEH SQQEEDGEEA MAGPPQGLFP G-NH2 |
5169.37 |
| 053-05 |
Pancreastatin / Chromogranin A (286-301)-Amide (Human) |
GESRSEALAV DGAGKPGAEE AQDPEGKGEQ EHSQQKEEEE EMAVVPQGLF RG-NH2 |
5505.54 |
| 053-56 |
Prepro-Chromogranin A (453-461) (Mouse) |
VAHQLQALR |
1035.21 |
| 053-57 |
Prepro-Chromogranin A (374-382) (Mouse) |
LEGEDDPDR |
1044.43 |
| 053-58 |
Prepro-Chromogranin A (78-88) (Mouse) |
ELQDLALQGA R |
1184.80 |
| 053-59 |
Prepro-Chromogranin A (291-302) (Mouse) |
TEASEALPSE GK |
1218.3 |
| 053-60 |
Prepro-Chromogranin A (339-348) (Mouse) |
QEEEEEEEER |
1335.29 |
| 053-61 |
Prepro-Chromogranin A (276-290) (Mouse) |
DDGQSDSQAV DGDGK |
1493.41 |
| 053-62 |
Prepro-Chromogranin A (435-452) (Mouse) |
AEDQELESLS AIEAELEK |
2004.16 |
| 053-18 |
Prepro-Chromogranin A (392-402) (Mouse) |
AYGFRDPGPQ L |
1219.6 |
| 053-26 |
Chromogranin A, Prepro (342-355) / WE-14 (Human) |
WSKMDQLAKE LTAE |
1809.88 |
| 053-05 |
Chromogranin A, Prepro (250-301) / Pancreastatin (Human) |
GESRSEALAV DGAGKPGAEE AQDPEGKGEQ EHSQQKEEEE EMAVVPQGLF RG |
5505.54 |
| 053-07 |
Chromogranin A, Prepro (286-301)-amide (Human) |
EEEEEMAVVP QGLFR-NH2 |
1817.85 |
| 053-37 |
Secretogranin I (372-380) (Rat) |
SEESQEKEY |
1127.46 |
| 053-38 |
Secretogranin I (416-432) (Rat) |
GRGREPGAYP ALDSRQE |
1857.91 |
| 053-21 |
Secretogranin I (513-532) (Rat) |
LGALFNPYFD PLQWKNSDFE |
2400.14 |
| 053-39 |
Secretogranin I (585-594) (Rat) |
SFAKAPHLDL |
1097.59 |
| 053-40 |
Secretogranin I (597-611) (Rat) |
Q (pyroglutamylation) YDDGVAELD QLLHY |
1760.79 |
| 004-89 |
Secretogranin I (375-383), prepro (Mouse) |
SEEDSQEREY |
1156.12 |
| 004-44 |
Secretogranin II (168-181) (Rat) |
FPLMYEENSR ENPF |
1771.8 |
| 004-45 |
Secretogranin II (169-181) (Rat) |
PLMYEENSRE NPF |
1624.73 |
| 047-95 |
Secretogranin II (184-216) / Secretoneurin (Rat) |
TNEIVEEQYT PQSLATLESV FQELGKLTGP SNQ |
3809.81 |
| 004-46 |
Secretogranin II (198-216) (Rat) |
ATLESVFQEL GKLTGPSNQ |
2018.04 |
| 004-47 |
Secretogranin II (205-216) (Rat) |
QELGKLTGPS NQ |
1270.65 |
| 004-48 |
Secretogranin II (287-316) (Rat) |
SGHLGLPDEG NRKESKDQLS EDASKVITYL |
3285.66 |
| 004-49 |
Secretogranin II (495-517) (Rat) |
PYDNLNDKDQ ELGEYLARML VKY |
2786.37 |
| 004-50 |
Secretogranin II (529-566) (Rat) |
VPSPGSSEDD LQEEEQLEQA IKEHLGQGSS QEMEKLAK |
4179.99 |
| 047-98 |
Secretogranin II (529-568) / Manserin (Rat) |
VPSPGSSEDD LQEEEQLEQA IKEHLGQGSS QEMEKLAKVS |
4366.09 |
| 047-69 |
EM-66 / Secretogranin II (219-284) (Rat) |
ERVDEEQKLY TDDEDDVYKT NNIAYEDVVG GEDWSPMEEK IETQTQEEVR DSKENTEKNE QINEEM |
7889.28 |
| 004-77 |
Secretogranin II (571-583) (Rat) |
IPAGSLKNED TPN |
1354.67 |
| 004-78 |
Secretogranin II (571-584) (Rat) |
IPAGSLKNED TPNR |
1510.78 |
| 004-79 |
Secretogranin II (571-585) (Rat) |
IPAGSLKNED TPNRQ |
1638.84 |
| 047-99 |
Secretogranin II (571-612) (Rat) |
IPAGSLKNED TPNRQYLDED MLLKVLEYLN QEQAEQGREH LA |
4867.43 |
| 004-80 |
Secretogranin II (595-611) (Rat) |
VLEYLNQEQA EQGREHL |
2055.01 |
| 060-41 |
Somatostatin (25-87) |
APSDPRLRQF LQKSLAAATG KQELAKYFLA ELLSEPNQTE NDALEPEDLP QAAEQDEMRL ELQ |
7093.62 |
| 004-39 |
Secretogranin III (23-36) (Rat) |
FPKPEGSQDK SLHN |
1582.78 |
| 004-85 |
Secretogranin III, prepro (20-54) (Human) |
FPKPGGSQDK SLHNRELSAE RPLNEQIAEA EEDKI |
3931.97 |
| 053-72 |
Secretogranin III Isoform 1, Prepro (233-246) (Mouse) |
VTPVAAVQDG FTNR |
1473.74 |
| 053-73 |
Secretogranin III Isoform 1, Prepro (441-453) (Mouse) |
DFINQQADAY VEK |
1539.72 |
| 053-74 |
Secretogranin III Isoform 1, Prepro (207-221) (Mouse) |
EANNYEETLD KPTSR |
1766.86 |
| 053-75 |
Secretogranin III Isoform 1, Prepro (99-115) (Mouse) |
SPPFDNQLNV EDADSTK |
1784.89 |
| 053-76 |
Secretogranin III Isoform 1, Prepro (178-202) (Mouse) |
LLNLGLITES QAHTLEDEVA EALQK |
2734.43 |
| 053-77 |
Secretogranin III Isoform 1, Prepro (319-343) (Mouse) |
YGTISPEEGV SYLENLDETI ALQTK |
2769.39 |
| 004-98 |
Secretogranin III , prepro (426-461) (Human) |
YGTISPEEGV SYLENLDETI ALQTK |
4145.02 |
| 046-94 |
Tachykinin III (95-115) |
NSQPDTPADV VEENTPSFGV L |
2215.04 |
| 065-11 |
Desamino-[D-Arg]-vasopressin / DDAVP |
Mpr-YFQNCP-dRG-NH2
Disulfide Bridge between Mpr1 & Cys6 |
1069.38 |
| 065-07 |
Provasopressin (24-32) |
Arginine-vasopressinCdYFQNCdPRG(amidation) |
1083.44 |
| 065-08 |
Provasopressin (26-32) |
FQNCPRG(amidation) |
819.38 |
| 065-42 |
Provasopressin (151-165) |
VQLAGTQESV DSAKP |
1528.77 |
| 065-43 |
Provasopressin (151-166) |
VQLAGTQESV DSAKPR |
1684.88 |
| 065-44 |
Provasopressin (151-167) |
VQLAGTQESV DSAKPRV |
1783.95 |
| 065-45 |
Provasopressin (151-168) |
VQLAGTQESV DSAKPRVY |
1947.01 |
| 065-46 |
Provasopressin (152-168) |
QLAGTQESVD SAKPRVY |
1847.94 |
| 065-47 |
Provasopressin (153-168) |
LAGTQESVDS AKPRVY |
1719.88 |
| 065-48 |
Provasopressin (154-168) |
AGTQESVDSA KPRVY |
1606.8 |
| 065-49 |
Provasopressin (155-168) |
GTQESVDSAK PRVY |
1535.76 |
| 064-15 |
VIP (125-137) (Rat) |
HSDAVFTDNY TRL |
1537.72 |
| 080-61 |
PEBP-1 (9-25) |
AGPLSLQEVD EPPQHAL |
1799.92 |
| 080-62 |
PEBP-1 (11-25) |
PLSLQEVDEP PQHAL |
1671.85 |
| 080-63 |
PEBP-1 (28-46) |
DYGGVTVDEL GKVLTPTQV |
1990.03 |
| 080-80 |
PEBP-1 (50-66) |
PSSISWDGLD PGKLYTL |
1847.93 |
| 080-65 |
PEBP-1 (174-187) |
DDSVPKLHDQ LAGK |
1521.78 |
| 065-71 |
GABA(A) receptor subunit alpha-6 (38-55) (Rat) |
NLLEGYDNRL RPGFGGAV |
1947.01 |
| 080-41 |
Dihydropyrimidinase-related protein 2 (518-572) (Rat) |
SAKTSPAKQQ APPVRNLHQS GFSLSGAQID DNIPRRTTQR IVAPPGGRAN ITSLG |
5761.09 |
| 080-42 |
Dihydropyrimidinase-related protein 2 (560-572) (Rat) |
APPGGRANIT SLG |
1209.65 |
| 080-43 |
Dihydropyrimidinase-related protein 3 (558-570) (Rat) |
APPGGRANIT SLS |
1255.65 |
| 010-67 |
salusin-alpha |
SGALPPAPAA PRPALRAQRA GPAGPGAK-NH2 |
2603.03 |
| 010-68 |
salusin-beta |
AIFIFIRWLL KLGHHGRAPP |
2342.87 |
| 010-74 |
salusin (40 mer) (Human) |
AIFIFIRWLL KLGHHGRAPP SGALPPAPAA PRPALRAQ |
4378.25 |
| 010-73 |
salusin (50 mer) (Human) |
AIFIFIRWLL KLGHHGRAPP SGALPPAPAA PRPALRAQRA GPAGPGAK-NH2 |
5240.26 |
| 024-03 |
BAM(8-22) |
VGRPEWWMDY QKRYG |
1971.23 |
| 060-50 |
Neuronostatin-13 (Human) |
LRQFLQKSLA AAA-NH2 |
1415.67 |
| 060-48 |
Neuronostatin-13 (Rat, Mouse) |
LRQFLQKSLA AAT-NH2 |
1445.7 |
| 060-52 |
Neuronostatin-19 (Rat) |
APSDPRLRQF LQKSLAAAT-NH2 |
2069.37 |
| 060-53 |
Neuronostatin-19 (Human) |
APSDPRLRQF LQKSLAAAA-NH2 |
2039.37 |
| 022-69 |
Pepcan-12 (Human, Mouse, Rat, Bovine , Porcine) |
RVDPVNFKLL SH |
1424.67 |
| 079-01 |
Phoenixin-14-amide (Human, Rat, Mouse, Pocrine, Ovine, Canine) |
EDVQPPGLKV WSDPF-NH2 |
1583.21 |
| 079-03 |
Phoenixin-20-amide (Human, Rat, Mouse, Canine) |
AGIVQEDVQP PGLKVWSDPF-NH2 |
2182.5 |
| 055-04 |
PTH (1-31) (Human) |
SVSEIQLMHN LGKHLNSMER VEWLRKKLQD V |
3719.38 |
| 026-81 |
Fractalkine precursor (25-104) / CX3CRL1 Chmokine domain |
pGlu-HHGVTKCNI TCSKMTSKIP VALLIHYQQN QASCGKRAII LETRQHRLFC ADPKEQWVKD AMQHLDRQAA ALTRNGGTFE
Disulfide bridges between CysA8 & CysA34 , CysA12 & CysB50 |
9053.82 |
| 012-14 |
Prepro-Augurin (133-148) (Rat) |
SREGFRHGAS VNYDDY |
1874.28 |
| 012-19 |
Prepro-Augurin (42-70) (Human) |
EAPVPTKTKV AVDENKAKEF LGSLKRQKR |
3268.84 |
| 012-20 |
Prepro-Augurin (42-70) (Mouse) |
EGPVPSKTNV AVAENTAKEF LGGLKRAKR |
3066.69 |
| 012-21 |
Augurin, Prepro (42-65) (Human) |
EAPVPTKTKV AVDENKAKEF LGSL |
2571.95 |
| 012-24 |
Prepro-Augurin (133-148) (Human) |
SPYGFRHGAS VNYDDY |
1847.92 |
| 012-26 |
Augurin (Human) |
pGluLWDRTRPEV QQWYQQFLYM GFDEAKFEDD ITYWLNRDRN GHEYYGDYYQ RHYDEDSAIG PR |
7843.80 |
| 023-81 |
Spexin / NPQ(Human, Mouse, Bovine) |
NWTPQAMLYL KGAQ-NH2 |
1619.91 |
| 023-82 |
Prepro-Spexin (36-58) (Human) |
NWTPQAMLYL KGAQGRRFIS DQS |
2668.03 |
| 023-83 |
Prepro-Spexin (37-116) (Human) |
WTPQAMLYLK GAQGRRFISD QSRRKDLSDR PLPERRSPNP QLLTIPEAAT
ILLASLQKSP EDEEKNFDQT RFLEDSLLNW |
5013.59 |
| 023-84 |
Prepro-Spexin (53-70) (Human) |
FISDQSRRKD LSDRPLPE |
2159.38 |
| 076-90 |
NERP-1 (Rat) |
LEGSFLGGSE AGERLLQQGL AQVEA-NH2 |
2558.3 |
| 076-89 |
NERP-1 / VGF Prepro (281-306) (Human) |
RPESALLGGS EAGERLLQQG LAQVEA-NH2 |
2678.99 |
| 076-91 |
NERP-2 (Human) |
pGlu-AEATRQAAA QEERLADLAD LASDLLLQYL LQGGARQRGL G-NH2 |
4080.55 |
| 076-92 |
NERP-2 (Rat) |
pGlu-AEATRQAAA QEERLADLAS DLLLQYLLQG GARQRDLG-NH2 |
4122.5 |
| 007-67 |
NERP-3 (177-206) / Prepro-VGF (177-206) (Human, Rat, Mouse) |
QQETAAAETE TRTHTLTRVN LESPGPERVW |
3406.69 |
| 007-71 |
NERP-4 / Prepro-VGF (485-503) (Human, Rat, Mouse) |
NAPPEPVPPP RAAPAPTHV |
1915.19 |
| 007-85 |
TLQP-21-amide (human) /Preprochromogranin A (429-454) |
TLQPPSALRR RHYHHALPPS R-NH2 |
2490.86 |
| 007-84 |
TLQP-21 (12-21)-amide (Human) |
HYHHALPPSR-NH2 |
1214.37 |
| 007-83 |
TLQP-21 (3-21)-amide, pGlu3 (Human) |
pGluPPSALRRRH YHHALPPSR-NH2 |
2259.58 |
| 007-86 |
TLQP-21 (13-21)-amide (Human) |
YHHALPPSR-NH2 |
1077.23 |
| 003-26 |
Nesfatin-1 (1-82) (Human) |
VPIDIDKTKV QNIHPVESAK IEPPDTGLYY DEYLKQVIDV LETDKHFREK
LQKADIEEIK SGRLSKELDL VSHHVRTKLD EL |
9551.86 |
| 003-22 |
Nesfatin-1 (1-82) (Rat) |
VPIDVDKTKV HNVEPVESAR IEPPDTGLYY DEYLKQVIEV LETDPHFREK
LQKADIEEIR SGRLSQELDL VSHKVRTRLD EL |
9582.8 |
| 032-35 |
adropin (34-76) (Human) |
CHSRSADVDS LSESSPNSSP GPCPEKAPPP QKPSHEGSYL LQP
Disulfide bridges between Cys34-Cys56 |
4499.9 |
| 046-74 |
Xenopsin 25 / Xinin 25 (Human) |
MLTKFETKSA RVKGLSFHPK RPWIL |
2970 |
| 028-61 |
Musclin / OSTN (83-112) (Human) |
SFSGFGSPLD RLSAGSVDHK GKQRKVVDHP |
3209.57 |
| 028-62 |
Musclin / OSTN (80-102) (Mouse) |
SFSGFGSPLD RLSAGSVEHR GKQ |
2419.80 |
| 028-63 |
Musclin / OSTN (116-133) (Human) |
FGIPMDRIGR NRLSNSRG |
2046.34 |
| 028-64 |
Musclin / OSTN (108-133) (Human) |
VVDHPKRRFG IPMDRIGRNR LSNSRG |
3034.54 |
| 028-65 |
Musclin (113-130) (Mouse) / Musclin (115-132) (Rat) |
RRVVDHSKKR FGIPMDRIGR NRLSSSRG |
2019.32 |
| 057-36 |
SCNH2 / Selective cutting Apelin-36 (1-16)-amide (Human) |
LVQPRGSRNG PGPWQG-NH2 |
1704.91 |
| 057-37 |
SCNH2 / Selective cutting Apelin-36 (1-16)-amide (Rat, Mouse) |
LVKPRTSRTG PGAWQG-NH2 |
1709.98 |
| 005-42 |
MCT-1 (Human) |
VTFLLPAGWI LSHLETYRRPE |
2498.91 |
| 005-44 |
MCT-2 (Human) |
(Formyl-M)TPMRKINPL MKLIN |
1828.33 |
| 005-16 |
MCT-CYC / Cytochrome C (68-80) (Human) |
LENPKKYIPG TKMIFVGI |
2048.54 |
| 012-52 |
PEDF-34 / Prepro-PEDF (44-77) (Human) |
DPFFKVPVNK LAAAVSNFGY DLYRVRSSTS PTTN |
3763.26 |
| 012-54 |
PEDF-44 / Prepro-PEDF (78-121) (Human) |
VLLSPLSVAT ALSALSLGAE QRTESIIHRA LYYDLISSPD IHGT |
4680.25 |
| 031-33 |
Ghrelin [Ser3-(Des-octanoyl)] |
GSS[Des Octanoyl]FLSPEHQ KAQQRKESKK PPAKLQPR |
3188.80 |
| 046-84 |
Hemokinin-1 (4-11) (Human) |
ASQFFGLM-NH2 |
899.08 |
| 055-51 |
OBAP (Rat,Mouse) |
LDLNLDLSKF RLPQPSSGRE SPRH |
2763.4 |
| 055-52 |
OBAP (Human) |
LDLNLELSKF RMPQPSSGRE SPRH |
2795.4 |
| 026-34 |
Alarin (Human) |
APAHRSSTFP KWVTKTERGR QPLRS |
2894.29 |
| 026-32 |
Alarin (Mouse) |
APAHRSSPFP PRPTRAGRET QLLRS |
2786.15 |
| 026-33 |
Alarin (Rat) |
APAHRSSTFQ PRPTRAGRQT QLLRS |
2820.17 |
| 075-32 |
YP-30 / Dermcidin (20-49) / Survival-promoting peptide |
YDPEAASAPG SGNPCHEASA AQKENAGEDP |
2970.05 |
| 075-33 |
Dermcidin / DCD-1L (Human) |
SSLLEKGLDG AKKAVGGLGK LGKDAVEDLE SVGKGAVHDV KDVLDSV |
4818.54 |
| 062-77 |
endortropohin (Mouse) |
EPLFLTKTDI CKLSRDAGTC VDFKLLWHYD LESKSCKRFW YGGCGGNENR FHSQEECEKM CSPELTV |
7883 |
| 062-79 |
endortropohin (Human) |
TEPLALTETD ICKLPKDEGT CRDFILKWYY DPNTKSCARF WYGGCGGNEN
KFGSQKECEK VCAPVLAKPG VISVMGT |
8584.2 |
